seed
Stage
About
Uses AI and protein design to create experimentally validated molecular affinity reagents for research teams and diagnostic developers, delivering high-performance reagents in weeks rather than months.
Explore Medium Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.